phosphatidylcholines has been researched along with precirol in 2 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (precirol) | Trials (precirol) | Recent Studies (post-2010) (precirol) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 81 | 0 | 52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CC; Fang, JY; Huang, ZR; Tsai, TH | 1 |
| Blanco-Prieto, MJ; Dios-Viéitez, Mdel C; Guada, M; Lana, H; Lasa-Saracíbar, B | 1 |
2 other study(ies) available for phosphatidylcholines and precirol
| Article | Year |
|---|---|
Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
Topics: Administration, Oral; Animals; Anticholesteremic Agents; Biological Availability; Chemical Phenomena; Delayed-Action Preparations; Diglycerides; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; Emulsifying Agents; Gastrointestinal Tract; Lipids; Lovastatin; Male; Nanoparticles; Particle Size; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Squalene; Surface Properties; Tissue Distribution | 2010 |
Lipid nanoparticles enhance the absorption of cyclosporine A through the gastrointestinal barrier: In vitro and in vivo studies.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Cyclosporine; Diglycerides; Female; Humans; Immunosuppressive Agents; Intestinal Absorption; Mice, Inbred BALB C; Nanoparticles; Phosphatidylcholines; Poloxamer; Polysorbates; Taurocholic Acid | 2016 |